International Journal of Molecular Sciences · 2025 · 10 citations · 52 references
PharmacyPharmaceuticsPharmacologyBioavailabilityDrug DeliveryOral Drug DeliveryControlled Release MechanismsDrug EncapsulationOral Bioavailability EnhancementOral NanocarriersPermeability EnhancementSolubility OptimizationDissolution Of Lipid-based FormulationsGut Barrier PermeabilityHydrophilicityLow PermeabilityOral Bioavailability OptimizationOral Drug Delivery SystemsPhospholipid-based FormulationsSolubility
Cannabidiol (CBD) has demonstrated therapeutic potential in treating epilepsy, multiple sclerosis, Alzheimer’s, Parkinson’s, and Crohn’s diseases. Despite its promising effects and analgesic, anti-inflammatory, and anxiolytic properties, oral CBD’s full potential is hindered by poor water solubility (0.7–10 μg/mL), low permeability, and chemical instability. This study aimed to enhance CBD’s dissolution, stability, and gastrointestinal (GI) permeability by forming a CBD–phospholipid complex (CBD-PLC). We hypothesised that CBD-PLC would enhance CBD’s hydrophilicity, thus improving GI barrier permeability. This study involved screening an optimal phospholipid (PL) using a Design of Experiments (DoE) approach to prepare CBD-PLC with nanosized droplets (194.3 nm). Dissolution studies revealed significantly enhanced release rates for CBD-PLC—44.7% at 2 h and 67.1% at 3 h—compared to 0% for pure CBD and 7.2% for a physical mixture (PM). Cellular uptake studies showed that at 30 µM, CBD-PLC exhibited 32.7% higher apparent permeability coefficients (Papp), nearly doubling at 40 µM compared to pure CBD. Cytotoxicity tests confirmed safety over 24 h, while 12-month stability tests demonstrated consistent performance under varied conditions. The results indicate that CBD-PLC improves CBD’s solubility, permeability, and stability, offering a promising strategy to address the limitations of oral CBD delivery systems.
52
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky, J. Helen Cross, Linda Laux et al. · New England Journal of Medicine · 2017 · 1.7K citations · Full text
Role of nanoparticle size, shape and surface chemistry in oral drug delivery
Amrita Banerjee, Jianping Qi, Rohan Gogoi et al. · Journal of Controlled Release · 2016 · 750 citations